Adverse events in diabetes drug trial
- PMID: 19801086
- DOI: 10.1016/S0140-6736(09)61736-0
Adverse events in diabetes drug trial
Comment on
-
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).Lancet. 2009 Jul 4;374(9683):39-47. doi: 10.1016/S0140-6736(09)60659-0. Epub 2009 Jun 8. Lancet. 2009. PMID: 19515413 Clinical Trial.
-
GLP-1 receptor agonists for type 2 diabetes.Lancet. 2009 Jul 4;374(9683):4-6. doi: 10.1016/S0140-6736(09)60942-9. Epub 2009 Jun 8. Lancet. 2009. PMID: 19515414 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical